Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2016-01-01
2017-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is therefore important that these regions are more widely available in the constitution of the world, and that they are suitable for use in the design of new technologies. Although MRI is the gold standard for soft tissue segmentation, it is not suitable for bone extraction; especially in the newborn or the bone is very thin. On the other hand, CTscan is an excellent method for extracting bone. The contrast between bone and soft tissue is excellent. In this case, with the CTscan, the fontanelles are identified as discontinuities between the images of the temporal scales.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebral Function Monitoring in Premature Infants
NCT00873847
Study of Bedside EEG to Evaluate Brain Injury in Premature Newborns
NCT00516334
Brain Structure and Development in Pre-Term and Full-Term Infants
NCT00679471
A MRI Study of Visual and Motor Pathways in Premature Infants
NCT01514747
neonAtal motoR paTtErn autoMatIc analySis
NCT06337136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The skull of the newborn is an inhomogeneous structure. The fontanelles are invisible in MRI and identifiable in CTscan.
Electroencephalography (EEG) and Near-Infrared Spectroscopy (NIRS). These sources are widely used to specify the source of certain evoked potentials or to better define the sources of epileptic graphoelements, especially in the pre-surgical assessment of refractory epilepsies.
It is therefore important that these regions are more widely available in the constitution of the world, and that they are suitable for use in the design of new technologies.
Although MRI is the gold standard for soft tissue segmentation, it is not suitable for bone extraction; especially in the newborn or the bone is very thin. On the other hand, CTscan is an excellent method for extracting bone. The contrast between bone and soft tissue is excellent. In this case, with the CTscan, the fontanelles are identified as discontinuities between the images of the temporal scales.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
term
50 CTscan and MRI images of children aged at term
CTscan and MRI images
CTscan and MRI images segmented according to procedures previously developed by GRAMFC
one month
50 CTscan and MRI images of children aged one month
CTscan and MRI images
CTscan and MRI images segmented according to procedures previously developed by GRAMFC
two months
50 CTscan and MRI images of children aged two months
CTscan and MRI images
CTscan and MRI images segmented according to procedures previously developed by GRAMFC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CTscan and MRI images
CTscan and MRI images segmented according to procedures previously developed by GRAMFC
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with no structural abnormalities
Exclusion Criteria
1 Day
2 Months
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabrice Wallois, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU AMIENS
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2017_843_0047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.